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~----'~ Genetic Polymorphlsma Renln-Anglotensln of  the 
System In Familial Dilated Cardlomyopathy 
T, Zoqal ~ , M, Vattn ~ , D, Gregorl, C, Recto, S, Mlocie ~ , M, Matultc ~ ,
M, Gtncra t , L, Mestronl ~ , International Centre for Genetic Engineering. 
Italy: t BIote(:hnology, Institute of Sf~ltlstics of the Unlversl~ Dcp,,lrtment of 
Cnrdiotog/ Hospital, 7}'testa, Italy 
In order to assaaa the role of the mn,n.nnglotensln 6yntem genes a~ ,u~cop- 
tibility factors, we tnvo#tlg~tod the a~t~oclatlon of the anglotensln.convafltno 
~n~ymo gone (ACE) the anglotanslnogen gone (AGT) and the gone for 
recaplor 1 el the anglotansln It (AT1) polymorphtsma with the Idlop,'tlhtc 
dilated e~rdlomyopathy (IDC) In n |lmuP of 41 famlltoe (20 with sporadic 
DO, 16 with autosomal dominant inl~rltance, 2 with X.tlnked OC and 3 with 
~ulo~omal dominant OC and myop~tl~y), Family t~tudle~ inchtdod clinical 
a~nmlnatlon, ECG and ocnocardlogrsphy of all available relatives, nnd full 
Inv~lve ewluatton of the p~tlonta, One hundred nnd seventeen of the In, ~tly 
members, (70 ~ffocted, 38 heallhy nnd 9 unknown) were genotypod for :he 
I/[3 polymorphlsm of ACE gone, angt,'~tanslnogen M~35T polymoq]h!~m ,nd 
Al16(~C potymot~hlsm of AT1 gone, The ACE genotype was an~tys~J by 
polymemse chain maatton wh0ma~ Ihe M235T of the AGT gone ns wall as 
A11(~6C c~f the ATI gone wore dotec=ted by Tth 111 1 digestion el the PCR 
prodoct, The frequency of the mut~te alleles and genotypos in the p~thtntn 
with DC ~nd In their relntlve~ worn enmpnmd with tl~etr frequency in a eOlttrOl 
gm~tp Oompo~ed by 100 healthy sublets and within different subgre, lps. 
The freq~lenay el M235T ~llele of the AGT gone in the hetero=ygeus and 
hemowgous form, resulted stgntflc~ttvely l~Igher In the subincta with DC m 
~ompafi~on with the oontrol gPoup (p =, 0,0004 for the presence 01 the mu, 
toted ntlele and p =~ 0.001 for the pmsonc(~ of the mutated genotype), On the 
other hand, the froquency of Al1(~6C allele 01 the AT1 gone and the result. 
tng mutated genotype were higher in the group with familial OC in respect 
of the patient~ with the sporadic term of DC (p ~ 0.0338 ,~nd p ~ 0,0492 
respectively). The data support II~a hypothe.~is that genetic variants o1 the 
genes involved ~n the renln-angiotensin system can represent susceptibility 
factors for the development of DC and in particular for the familial form el the 
disease, 
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~The Anglotenaln Converting Enzyme DD Genntype 
la Associated With a Decreased Response to 
Angloteneln II In Human Arteries 
P,P van Gaol, A,A Voom, M. Oostorgn, Y.M. Pinto, H. Buikoma, A. van 
Button, H,J,G.M, Cain.% J.H Kingmn, W.H. van Gitst. University of 
Groningen and St, Antom¢~s Hospital N~eut~%lein, The Netherlands 
Background: The delohon tvpe (DD) gano for the angiotonsm converting 
enzyme lACE) seems to be involved ~n cardiovascular disease, and has 
been associated with n higher plasma ACE-activity However, the influence 
of the ACE-genotype on functional vascular responses to angiotensin (Ang) 
II remains uncertain. 
Method~: From 137 potionts undergoing coronary bypass surgery, excess 
int~mal mammary arlones worn han/ested. Aden/nngs wore contracted to 
Ang II (0,1 aM-1 I~M) in o~an baths, end responses were expressed as the 
pomontago el the response to 10 I~M phonylephnno. 
Re.~ulfs: Patients with the DD gonotypo (n = 38) had increased plasma 
ACE-activily levels compared fo patients with the II/ID gonotypo (n = 99) 
(DD 26,9 ~: 1.2 U,,I. vs. II/ID 21.3 ± 1.0 U/L, p = 0,002), Functional vascular 
responses to Ang II were decmosod in the DD group. Maximal contraction 
in the DD group (n = 13) was 36.2 ~- 5.1% compared to 55.7 ~: 4.6% in the 
IltlD o~mt=e (n = 25) (p = 0.01). 
Conclusion: The ACE DD genotype is associated with an increased 
plasma ACE-activity and a decreased vascular response to Ang I.  These 
findings might be explained by a down regulation of AT1 rocoptom m re- 
sponse to an activated renin-angiotensin system. 
[• Coronary Stents: Radiation and Stent Grafts 
Wednesday, April 1, 1998, 8:30 a,rn.-10:00 a.m. 
Georgia World Congress Center, Lecture Hall 3 
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~ Short-term (1 Month) Reaults of the Oole Response 
IRIS FeaIlblllty_ Study of a B,Jta-Partl©la Emitting 
Radioisotope Stoat 
J,W, Manes, 8G,  Ellis, S,R, Bailey, B,O. Raybuck, P$~ Teirstein, 
N,J, Wei~m~n, J,J, Popm,,1, For the IRIS Investigafor~, Leno~ HIlt HOspital, 
New York, NY, USA 
Recent investigations ttggest that local m~diation and stent!ng may ~uce  
rOstenosis post PTCA. The expansion phase el the IsoStents for Rostenosts 
Intenmntion Study (IRIS) is designed to determine the safety el implanting 
Palmaz-Schat~ coronary stents with ~ level el radioactivity (0.75 I,Ci--.t.50 
i,Ci) above the original feasibility study (0,50 j~Ci-tO0 ~,Ci). Radioachvtty 
IS impadod by 0mbeddtng th0 pure bota.paflicle emitter, phosphorous.3P. 
(P3.~), beneath the sudaco o! the slant. Average slant activity was t ~0~ ~¢Ct 
at implnnt, 27 radioisotope slants w~re euccesstu!ly ~mplanted m de nova (n 
= P-~) or restenotic (n = 3) lesions in 25 patients (LAD = t l ,  Ctre = 7, RCA = 
7). 
QC^ mSuiis tn ~ t,t) Pm Post 
Reference vessel 2 e~ t 0 46 2 98 i 0 55 
Percent stenosls 681 t 14 ~ 00 t 15, 
Mlnlmttm Lumen Diem.tar Ot'lt 1 050 28; = t 0 31 
At 30 days, no patients had vessel closure, any MI, target vessel revas- 
culanzatton, doatl~ or noutropenia. Six month chnlcaL angtographtc, and 
inlravaseular ullrasound follow.up will be presented. 
Cone/asians: P32 radloisotopo slants can be safely tmplanted with a h~h 
immediate success rate and no unexpected adverse events at one monm. 
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~A/3 -emi t t ing  Liqutd Isotope Filled Balloon Markedly 
Inhibits Restenosis in Stented Porcine Coronary 
Arteries 
R. Makkar, J. Whiting, A. Li, H. Cordoro, H Honda, A. Fnmemnan, 
F. Litvack, N. Eigler. Cedars-Sinai &'radical Center. Los Angeles. CA. USA 
Background: We hypothesized that a balloon based hqutd p-emitting brachyther- 
spy would r0sult in homogeneous dose distnbution and more effectively 
inhibit slant restenosLs. 
Methods and Results: Efficacy at Re ~ td : t~ ~ = 17 hours) tdled balloon 
catheter was tested =n a 30 day porcine coronary model ot m-slant restenos~s 
in a random=zed operator blinded prOtoCol. In 7 normolipemic pigs, 20 mm 
segment of coronary artenal wail to left antenor descending or oght coronary 
artery was pretmated with a balloon catheter tilled with FIe ta~ or normal 
saline (n = 6 orleans in each group) followed by overstretch lnlury stem 
implantation. Average treatment times were 7 minutes both for saline and 
Re t~ group to deliver doses of 14 Gy at 0,5 mm tissue depth. Restenosis was 
assessed by measunng mean and max=mum percent stenosls by quantitatwe 
coronary angiography and neointimot area (IA) by intravascular ultrasound 
(IVUS). Mean exposure to the operators was below 5 mRem/treatment. Blood 
samples showed no leak of radioactive marshal 
Angtographic stenosis (%) IVUS 
Mean Maximum IA (ram 2) Area stenosl$ 
Placebo 60 -t 9 62 :t 11 3.3 ± 26 41 ± 21°'o 
Re 1~9 tO ~ 17' 32 ± 2;~ ~ 0.  ~ ± 06" 17 ± t1%" 
p - 0.01, ~ p • 0.05. Results o1 hlstomorphometPt will be presented. 
Conclusion: Treatment with Re ~"8 filled balloon peer to stenting effective;y 
inhibits (re)stenosis in porcine coronaries and is logistically feasible 
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~l~.~duct lon  of Neointimal Proliferation After 
Implantation of a Beta Particle Emitting Gold Au 198 
Coated Stent 
E. AIt, R.A. Herrmann, A. Rybnikar, J.B. Knebel, G. Ritscher. B. M~rkl, 
J. Hausleiter, I. Wolf 1 , W. Erhardt, M. Schwaigor t, A. SchSmig. I. Med. Klin~k 
and Deutsches Herzzentrum, Germany: ~ Nuklearmed. K/inik, Klinikum 
rechts der tsar, Technische Universittit ME~nchen, Germany 
Background: Restenosis following intracoronary stent placement continues 
